BETA DRUGS

beta-drugs-logo

Beta Drugs is a drug delivery system that differentiates itself and increases patient compliance. They promote patient compliance, are simple to use, prevent dosing mistakes, and reduce drug waste. They create and market sophisticated oncology medications.

#SimilarOrganizations #Website #More

BETA DRUGS

Social Links:

Industry:
Health Care Manufacturing Medical Pharmaceutical

Founded:
1993-01-01

Address:
Haryana, Haryana, India

Country:
India

Website Url:
http://www.betadrugslimited.com

Total Employee:
1+

Status:
Active

Contact:
91-172-2585481-3

Email Addresses:
[email protected]

Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Apple Mobile Web Clips Icon Google Font API Google Tag Manager Google Analytics Google Maps Global Site Tag Google Analytics 4 Google Maps API


Similar Organizations

biotoxtech-logo

Biotoxtech

Biotoxtech engaged in the provision of manufacturing non-clinical drugs.

chimin-health-management-logo

Chimin Health Management

Chimin Health Management manufactures pharmaceutical products.

interojo-logo

Interojo

Interojo manufactures multifocal, silicone disposable eye lenses.

pharmedic-laboratories-logo

Pharmedic Laboratories

Pharmedic Laboratories manufactures and supplies anti-cancer drugs.

samil-pharmaceutical-logo

Samil Pharmaceutical

Samil Pharmaceutical manufactures pharmaceutical drugs

tibet-weixinkang-medicine-logo

Tibet Weixinkang Medicine

Tibet Weixinkang Medicine manufactures pharmaceutical products.

zhejiang-yatai-pharmaceutical-logo

Zhejiang Yatai Pharmaceutical

Zhejiang Yatai Pharmaceutical is a manufacturer of medical drug products.

Stock Details


Company's stock symbol is NSE:BETA

Official Site Inspections

http://www.betadrugslimited.com Semrush global rank: 10.07 M Semrush visits lastest month: 268

  • Host name: s3742.bom1.stableserver.net
  • IP address: 190.92.174.128
  • Location: Argentina
  • Latitude: -34.6022
  • Longitude: -58.3845
  • Timezone: America/Argentina/Buenos_Aires

Loading ...

More informations about "Beta Drugs"

TH ANNUAL REPORT BETA DRUGS LIMITED

Email: [email protected] Corporate Office : SCO-184, Sector-5, Panchkula-134114 Ph no. 0172-2585481,483 Statutory Auditors:M/s Kalra Rai & Associates, Chartered Accountants, …See details»

BETA DRUGS LIMITED Company Profile - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for BETA DRUGS LIMITED of Panchkula, Haryana. Get the latest business insights from Dun & Bradstreet.See details»

Beta Drugs Limited | Company Details | The Company Check

Aug 12, 2024 Beta Drugs Limited (BDL) is a leading Public Limited Indian Non-Government Company incorporated in India on 21 September 2005 and has a history of 19 years and five …See details»

Beta Drugs (NSE:BETA) Company Profile & Description - Stock …

4 days ago Beta Drugs Limited develops, manufactures, and sells anti-cancer drugs in India. The company offers oncology products in the areas of breast, lung, head and neck, colorectal, …See details»

betadrugslimited.com - Whois.com

Aug 16, 2017 Whois Lookup for betadrugslimited.com. Domain Services Transfer your Domain Consolidate your domains quickly & easily Free With Every Domain Free services included …See details»

Beta Drugs - Crunchbase Company Profile & Funding

Beta Drugs is a drug delivery system that differentiates itself and increases patient compliance. They promote patient compliance, are simple to use, prevent dosing mistakes, and reduce drug waste.See details»

Beta Drugs Ltd. - Drug pipelines, Patents, Clinical trials - Synapse

Explore Beta Drugs Ltd. with its drug pipeline, therapeutic area, technology platform, .See details»

Beta Drugs - Company Profile - Tracxn

Mar 3, 2025 Beta Drugs - Developer of therapeutics for oncology and dermatology. Public Company. Raised funding over 1 round from 1 investor. Founded by Vijay Batra in the year …See details»

17TH ANNUAL REPORT BETA DRUGS LIMITED

Website: www.betadrugslimited.com Email: [email protected] Corporate Office : SCO-184, Sector-5, Panchkula-134114 Ph no. 0172-2585481, 483 Statutory Auditors: M/s Kalra Rai …See details»

Beta Drugs - Craft

Aug 30, 2024 Revenue (FY, 2024)₹3.0B Gross profit (FY, 2024)₹1.5B Net income (FY, 2024)₹364.4M Cash (FY, 2024)₹286.3M EBIT (FY, 2024)₹515.7MSee details»

Beta Drugs - Overview, News & Similar companies | ZoomInfo.com

View Beta Drugs (www.betadrugslimited.com) location in Himachal Pradesh, India , revenue, industry and description. Find related and similar companies as well as employees by title and …See details»

16TH ANNUAL REPORT BETA DRUGS LIMITED

16TH ANNUAL REPORT BETA DRUGS LIMITED 37 Total Shares Total Shares A. Promoter 1) Indian a) Individual/ HUF 6352923 - 6352923 66.08 6410523 - 6410523 66.68 0.6 b) Central …See details»

BETA DRUGS LIMITED

BETA DRUGS LIMITED BDLIPKL/SEC/2022 27tn ocrober,2022 Natlonal Stock Exchange of India Ltd. Excha nge Plaza, 5th Floor Plot no. C/1, G Block Ba nd ra-Ku rla Complex, Bandra (E) …See details»

BDL - Beta Drugs Ltd. Information - RocketReach

Betadrugslimited.com; 2 97152890XXXX; 91937703XXXX; Ashutosh Shukla Director at BDL - Beta Drugs Ltd. Chandigarh, CH, IN View. 2 gmail.com; betadrugslimited.com; 2 …See details»

Beta Drugs LEI 984500A89888DB9E6T57 - Cbonds.com

Beta Drugs. Information about the issuer. News and credit ratings. (LEI 984500A89888DB9E6T57). Tables with accounting and financial reporting.See details»

Investor Presentation - betadrugslimited.com

Branded Prescription Business API BUSINESS International Market Strengthening the Haematology basket with the launch of Carfimib (Carfilzomib) Top 10 brands contributing 50% …See details»

Company Profile-Beta Drugs Ltd | BFSL - motisonsshares.com

Registered Office : Village Nandpur, Lodhimajra Road, Distt Solan, Baddi, Himachal Pradesh - 174101: Tel: 01795-236196See details»

Beta Drugs Ltd, BETA:NSI profile - FT.com - Financial Times

Mar 13, 2025 Beta Drugs Limited is an India-based oncology medicine manufacturing company. The Company specializes in the intricate field of complex chemical synthesis for anti-cancer …See details»

Investor Presentation FY 2021-22 - betadrugslimited.com

Healthy Growth across all verticals in FY’22 6 Domestic Own brand International 67% revenue growth 15% revenue growth 65% revenue growth 67% revenue growthSee details»

Investor Presentation - betadrugslimited.com

Jun 11, 2024 30 % growth* 141 % growth 20 % growth International API Business business DOMESTIC OWN BRAND Healthy Growth in H1’25(Y-O-Y) * Including cosmeceutical salesSee details»

linkstock.net © 2022. All rights reserved